A responsible approach backed by scientific rigor

Intro section

We are building a range of high-quality cannabinoid products that patients and consumers can trust, that are well-characterized and enable dose titration, with the aim of improving options for physicians, patients, and consumers.

We publish our science in peer-reviewed journals and our ambition is to develop innovative products with safe and effective delivery systems for targeted populations and outcomes.

Useful resources

Read the details of our research

Read more

Collaborating with the industry

01

We collaborate with other responsible organizations to inform evidence-based frameworks and quality standards for cannabinoid products

We work with industry partners, academic institutions, and regulatory bodies worldwide to improve evidence-based frameworks for cannabinoid product quality, safety, and predictability.

Our team of experts and scientists participates in working groups and committees, such as the ASTM International #D37 Committee on Cannabis.

We believe that robust, science-backed regulations not only protect patients and consumers but also create an environment where responsible innovation can flourish.

02

We are committed to excellence in cannabinoid education and information

We promote open and accessible information and resources.

We support and provide structured medical education programs for our stakeholders.

Quality

We have end-to-end oversight of all our products, ensuring that high-quality standards at every stage are adopted and met.

From botany to bioavailability, through product purity to stability, to dose control and responsible commercialization. Every step is carefully managed and monitored.